SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bacil Pharma proposes to incorporate wholly-owned subsidiary

18 Jun 2026 Evaluate

Bacil Pharma has proposed to incorporate a wholly-owned subsidiary company in the name and style of ‘Bacil Research & Development’, subject to approval of the Registrar of Companies and other applicable statutory authorities.

The proposed company shall be incorporated as a private limited company. The incorporation is proposed with the objective of undertaking research and development activities and such other allied activities as may be permitted under applicable laws.

Bacil Pharma is primarily engaged in healthcare solutions focusing on the development, manufacturing, and distribution of pharmaceutical formulations including tablets, capsules, ointments, injectables, and specialty products. All operations comply with the relevant regulatory and quality standards.


Bacil Pharma Share Price

39.75 -2.09 (-5.00%)
25-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1862.15
Dr. Reddys Labs. 1350.00
Cipla 1440.30
Zydus Lifesciences 1101.50
Lupin 2342.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: